Christopher B. Ehrlich
Chairman and CEO, Director · CERO THERAPEUTICS HOLDINGS, INC.
Individual
- 2024
- Jan 9, 2026
- 4
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Christopher B. Ehrlich. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- YK Bioventures Opportunities GP I, LLC - $1.11M in CERO purchases and sales on record
- Stuart M. Sloan - $56K in CERO purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher B. Ehrlich?
Christopher B. Ehrlich is a corporate insider, tracked as Chairman and CEO, Director of CERO THERAPEUTICS HOLDINGS, INC. (CERO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher B. Ehrlich last file a Form 4?
The most recent primary Form 4 on record is dated 9 January 2026, one of 4 filings going back to 2024.
